{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:01:59Z","timestamp":1780506119183,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clnesp.2020.12.025","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T02:02:24Z","timestamp":1613613744000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Bifidobacterium longum W11: Uniqueness and individual or combined clinical use in association with rifaximin"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-8675","authenticated-orcid":false,"given":"Francesco","family":"Di Pierro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3575-6919","authenticated-orcid":false,"given":"Marco","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2020.12.025_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/jvim.14875","article-title":"The gastrointestinal microbiome: a review","volume":"32","author":"Barko","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.clnesp.2020.12.025_bib2","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2020.12.025_bib3","first-page":"43","article-title":"The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession","volume":"2","author":"Reuter","year":"2001","journal-title":"Curr Issues Intest Microbiol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13052-020-0781-0","article-title":"The infant gut microbiome as a microbial organ influencing host well-being","volume":"46","author":"Turroni","year":"2020","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.clnesp.2020.12.025_bib5","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1111\/1462-2920.14705","article-title":"Bifidobacterium bifidum and the infant gut microbiota: an intriguing case of microbe-host co-evolution","volume":"21","author":"Duranti","year":"2019","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib6","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.3748\/wjg.v20.i27.8796","article-title":"Irritable bowel syndrome: a concise review of current treatment concepts","volume":"20","author":"Wall","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01659-16","article-title":"Complete genome sequence of Bifidobacterium longum W11 (LMG P-21586), used as a probiotic strain","volume":"5","author":"Inturri","year":"2017","journal-title":"Genome Announc"},{"key":"10.1016\/j.clnesp.2020.12.025_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00284-008-9135-7","article-title":"Resistance to simulated gastrointestinal conditions and adhesion to mucus as probiotic criteria for Bifidobacterium longum strains","volume":"56","author":"Izquierdo","year":"2008","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib9","first-page":"1787","article-title":"Scanning electron microscopy observation of adhesion properties of Bifidobacterium longum W11 and chromatographic analysis of its exopolysaccaride","volume":"5","author":"Inturri","year":"2014","journal-title":"Food Nutr Sci"},{"key":"10.1016\/j.clnesp.2020.12.025_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.carbpol.2017.07.039","article-title":"Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum","volume":"174","author":"Inturri","year":"2017","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.clnesp.2020.12.025_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2249.2007.03522.x","article-title":"Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications","volume":"150","author":"Medina","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib12","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/01.mcg.0000128937.32835.7c","article-title":"Clinical experience with probiotics in the elderly on total enteral nutrition","volume":"38","author":"Del Piano","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib13","first-page":"349","article-title":"Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study","volume":"52","author":"Colecchia","year":"2006","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib14","first-page":"111","article-title":"Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms","volume":"78","author":"Dughera","year":"2007","journal-title":"Acta Biomed"},{"key":"10.1016\/j.clnesp.2020.12.025_bib15","first-page":"157","article-title":"Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11\u00a0+ FOS Actilight)","volume":"77","author":"Amenta","year":"2006","journal-title":"Acta Biomed"},{"key":"10.1016\/j.clnesp.2020.12.025_bib16","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3748\/wjg.v23.i25.4491","article-title":"Eubiotic properties of rifaximin: disruption of the traditional concepts in gut microbiota modulation","volume":"23","author":"Ponziani","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib17","first-page":"85","article-title":"Role of gut microflora and probiotic effects in the irritable bowel syndrome","volume":"77","author":"Fanigliulo","year":"2006","journal-title":"Acta Biomed"},{"key":"10.1016\/j.clnesp.2020.12.025_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.15403\/jgld.2014.1121.274.rif","article-title":"Rifaximin for the management of colonic diverticular disease: far beyond a simple antibiotic","volume":"27","author":"Tursi","year":"2018","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1016\/j.clnesp.2020.12.025_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/DCR.0b013e318223cb2b","article-title":"Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review","volume":"54","author":"Maconi","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clnesp.2020.12.025_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.medmal.2017.07.001","article-title":"Antibiotic susceptibility of probiotic strains: is it reasonable to combine probiotics with antibiotics?","volume":"47","author":"Neut","year":"2017","journal-title":"Med Maladies Infect"},{"key":"10.1016\/j.clnesp.2020.12.025_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-1605(98)00051-8","article-title":"Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes","volume":"41","author":"Tynkkynen","year":"1998","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.clnesp.2020.12.025_bib22","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1097\/MCG.0000000000000683","article-title":"The possible innovative use of Bifidobacterium longum W11 in association with rifaximin: a new horizon for combined approach?","volume":"50","author":"Graziano","year":"2016","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.clnesp.2020.12.025_bib23","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.43.11.2813","article-title":"Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus","volume":"43","author":"Wichelhaus","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clnesp.2020.12.025_bib24","first-page":"2740","article-title":"EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance","volume":"10","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.clnesp.2020.12.025_bib25","first-page":"259","article-title":"Effects of rifaximin-resistant Bifidobacterium longum W11 in subjects with symptomatic uncomplicated diverticular disease treated with rifaximin","volume":"65","author":"Di Pierro","year":"2019","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"4","key":"10.1016\/j.clnesp.2020.12.025_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095476","article-title":"Short-term effect of antibiotics on human gut microbiota","volume":"9","author":"Panda","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.clnesp.2020.12.025_bib27","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"52","author":"Malaguarnera","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnesp.2020.12.025_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","article-title":"Bifidobacterium longum with fructo-oligosaccharides in patients with non-alcoholic steatohepatitis","volume":"57","author":"Malaguarnera","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnesp.2020.12.025_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.1016\/j.clnesp.2020.12.025_bib30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrcardio.2017.169","article-title":"Atherosclerosis: association between the gut microbiome and atherosclerosis","volume":"14","author":"Barrington","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.clnesp.2020.12.025_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11906-017-0734-1","article-title":"The gut, its microbiome, and hypertension","volume":"19","author":"Richards","year":"2017","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"10.1016\/j.clnesp.2020.12.025_bib32","first-page":"99","article-title":"Gut microbiome: pertinence in fibromyalgia","volume":"38","author":"Minerbi","year":"2020","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:58:17Z","timestamp":1762498697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457721000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":32,"alternative-id":["S2405457721000528"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2020.12.025","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bifidobacterium longum W11: Uniqueness and individual or combined clinical use in association with rifaximin","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2020.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}